ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for TCRX

Stock NameTscan Therapeutics Inc
TickerTCRX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS89854M1018

Show aggregate TCRX holdings

News associated with TCRX

BNP Paribas Financial Markets Purchases Shares of 65,139 TScan Therapeutics, Inc. (NASDAQ:TCRX)
BNP Paribas Financial Markets acquired a new position in shares of TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 65,139 shares of the company’s stock, valued at approximately $198,000. A number of other institutional investors and hedge funds have […] - 2025-05-30 04:24:59
Analyzing TScan Therapeutics (NASDAQ:TCRX) & Relay Therapeutics (NASDAQ:RLAY)
TScan Therapeutics (NASDAQ:TCRX – Get Free Report) and Relay Therapeutics (NASDAQ:RLAY – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, risk and dividends. Analyst Ratings This is a breakdown of […] - 2025-05-27 02:48:56
TScan Therapeutics (NASDAQ:TCRX) versus Novonesis A/S (OTC:NVZMY) Head-To-Head Comparison
TScan Therapeutics (NASDAQ:TCRX – Get Free Report) and Novonesis A/S (OTC:NVZMY – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations and profitability. Profitability This table compares TScan Therapeutics and Novonesis […] - 2025-05-19 02:48:47
Stifel Financial Corp Boosts Holdings in TScan Therapeutics, Inc. (NASDAQ:TCRX)
Stifel Financial Corp lifted its stake in TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) by 10.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 109,700 shares of the company’s stock after purchasing an additional 10,567 shares during the period. Stifel […] - 2025-05-14 04:56:49
Renaissance Technologies LLC Has $32,000 Stake in TScan Therapeutics, Inc. (NASDAQ:TCRX)
Renaissance Technologies LLC reduced its stake in shares of TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) by 85.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,600 shares of the company’s stock after selling 63,400 shares during the quarter. Renaissance […] - 2025-05-09 04:38:54
TScan Therapeutics, Inc. (NASDAQ:TCRX) Shares Sold by Marshall Wace LLP
Marshall Wace LLP cut its holdings in shares of TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) by 73.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 43,969 shares of the company’s stock after selling 121,191 shares during the quarter. Marshall Wace LLP owned about […] - 2025-05-06 04:51:00
TScan Therapeutics (NASDAQ:TCRX) Earns Buy Rating from Needham & Company LLC
TScan Therapeutics (NASDAQ:TCRX – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at Needham & Company LLC in a research note issued to investors on Tuesday,Benzinga reports. They currently have a $9.00 target price on the stock. Several other brokerages have also recently commented on TCRX. HC Wainwright restated a “buy” […] - 2025-04-10 04:13:06
TScan Therapeutics (NASDAQ:TCRX) & Novavax (NASDAQ:NVAX) Financial Comparison
TScan Therapeutics (NASDAQ:TCRX – Get Free Report) and Novavax (NASDAQ:NVAX – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, valuation, risk, dividends and analyst recommendations. Insider & Institutional Ownership 82.8% of TScan Therapeutics […] - 2025-03-14 04:28:44
Barclays Issues Pessimistic Forecast for TScan Therapeutics (NASDAQ:TCRX) Stock Price
TScan Therapeutics (NASDAQ:TCRX – Free Report) had its price objective trimmed by Barclays from $14.00 to $3.00 in a report published on Friday,Benzinga reports. The firm currently has an overweight rating on the stock. A number of other equities research analysts also recently weighed in on the stock. Wedbush restated an “outperform” rating and issued […] - 2025-03-10 04:14:46
abrdn plc Purchases 512,049 Shares of TScan Therapeutics, Inc. (NASDAQ:TCRX)
abrdn plc lifted its position in shares of TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) by 137.8% during the 4th quarter, HoldingsChannel reports. The fund owned 883,704 shares of the company’s stock after purchasing an additional 512,049 shares during the period. abrdn plc’s holdings in TScan Therapeutics were worth $2,686,000 at the end of the […] - 2025-02-10 16:44:59
China Universal Asset Management Co. Ltd. Invests $32,000 in TScan Therapeutics, Inc. (NASDAQ:TCRX)
China Universal Asset Management Co. Ltd. bought a new position in TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 10,410 shares of the company’s stock, valued at approximately $32,000. A […] - 2025-02-05 06:46:55

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) TCRX holdings

DateNumber of TCRX Shares HeldBase Market Value of TCRX SharesLocal Market Value of TCRX SharesChange in TCRX Shares HeldChange in TCRX Base ValueCurrent Price per TCRX Share HeldPrevious Price per TCRX Share Held
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TCRX by Blackrock for IE00BYXG2H39

Show aggregate share trades of TCRX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-06BUY2402.0502.228 2.210USD 530 1.78
2025-10-03BUY5602.1102.276 2.259USD 1,265 1.78
2025-10-02BUY802.1802.300 2.288USD 183 1.78
2025-09-30BUY1601.8201.825 1.825USD 292 1.78
2025-09-26BUY1601.8501.860 1.859USD 297 1.78
2025-09-25BUY1601.7801.855 1.848USD 296 1.78
2025-09-18BUY801.7201.730 1.729USD 138 1.78
2025-09-17BUY2401.6001.740 1.726USD 414 1.78
2025-09-11SELL-801.8501.860 1.859USD -149 1.78 Loss of -7 on sale
2025-09-10BUY1601.8401.880 1.876USD 300 1.78
2025-09-05SELL-801.9101.960 1.955USD -156 1.77 Loss of -14 on sale
2025-08-29SELL-2401.8001.860 1.854USD -445 1.77 Loss of -19 on sale
2025-08-27BUY1601.8701.950 1.942USD 311 1.77
2025-08-26SELL-801.8901.930 1.926USD -154 1.77 Loss of -12 on sale
2025-08-25BUY801.9001.930 1.927USD 154 1.77
2025-08-20SELL-3201.7001.750 1.745USD -558 1.77 Profit of 9 on sale
2025-08-18BUY1601.7901.840 1.835USD 294 1.77
2025-08-08SELL-1601.6401.700 1.694USD -271 1.77 Profit of 13 on sale
2025-08-05BUY801.7501.780 1.777USD 142 1.78
2025-08-01SELL-2401.6201.768 1.753USD -421 1.78 Profit of 6 on sale
2025-07-30BUY3201.8101.860 1.855USD 594 1.78
2025-07-17SELL-1601.8901.940 1.935USD -310 1.77 Loss of -26 on sale
2025-07-11SELL-6401.8101.855 1.851USD -1,184 1.77 Loss of -51 on sale
2025-07-07BUY2401.4501.550 1.540USD 370 1.77
2025-07-02BUY4,3451.4701.540 1.533USD 6,661 1.78
2025-06-25BUY1581.5401.690 1.675USD 265 1.79
2025-06-11BUY1581.6001.789 1.770USD 280 1.81
2025-06-10BUY1581.6901.869 1.851USD 292 1.81
2025-06-04SELL-791.7801.810 1.807USD -143 1.82 Profit of 1 on sale
2025-04-23BUY791.6301.670 1.666USD 132 1.97
2025-04-10SELL-6401.1301.190 1.184USD -758 2.05 Profit of 554 on sale
2025-04-08SELL-801.1801.360 1.342USD -107 2.08 Profit of 59 on sale
2025-04-07SELL-801.2601.310 1.305USD -104 2.09 Profit of 63 on sale
2025-04-04SELL-4001.1001.260 1.244USD -498 2.11 Profit of 345 on sale
2025-04-01BUY3201.2701.460 1.441USD 461 2.13
2025-03-31SELL-2401.3801.450 1.443USD -346 2.15 Profit of 169 on sale
2025-03-14SELL-1,2801.7401.890 1.875USD -2,400 2.28 Profit of 519 on sale
2025-03-07SELL-1601.9802.095 2.084USD -333 2.33 Profit of 40 on sale
2025-03-04SELL-802.0202.040 2.038USD -163 2.36 Profit of 25 on sale
2025-02-25BUY1602.0502.180 2.167USD 347 2.41
2025-02-19SELL-802.0802.150 2.143USD -171 2.44 Profit of 24 on sale
2025-02-13BUY2402.0402.130 2.121USD 509 2.50
2025-02-12BUY802.1102.150 2.146USD 172 2.52
2025-02-11BUY3202.0802.180 2.170USD 694 2.53
2025-01-17BUY3202.4002.500 2.490USD 797 2.75
2025-01-16BUY3202.4602.640 2.622USD 839 2.79
2025-01-10SELL-1602.7702.800 2.797USD -448 2.93 Profit of 21 on sale
2025-01-08SELL-3202.8503.000 2.985USD -955 3.08 Profit of 32 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TCRX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1944,5720124,20335.9%
2025-09-1851,6380160,53632.2%
2025-09-1742,1700193,04321.8%
2025-09-1624,1403666,57836.3%
2025-09-1584,32417227,68237.0%
2025-09-1241,9250106,44139.4%
2025-09-1188,0341,150183,13448.1%
2025-09-1082,912300258,14332.1%
2025-09-0932,3810125,75925.7%
2025-09-0823,483084,00728.0%
2025-09-0585,9940190,51945.1%
2025-09-0417,928056,25431.9%
2025-09-0342,1600149,38828.2%
2025-09-0215,023086,53917.4%
2025-08-297,861029,99326.2%
2025-08-2835,867080,99044.3%
2025-08-275,828057,90310.1%
2025-08-2657,8720206,33028.0%
2025-08-2524,0440110,85421.7%
2025-08-2229,5150181,00116.3%
2025-08-2139,2870121,80832.3%
2025-08-2016,378069,05923.7%
2025-08-1963,284100129,96548.7%
2025-08-1813,791052,87726.1%
2025-08-1517,964078,57122.9%
2025-08-1461,9100207,34629.9%
2025-08-1343,8870165,72326.5%
2025-08-1239,2660130,20330.2%
2025-08-117,561048,85915.5%
2025-08-0821,195066,14432.0%
2025-08-0775,7750147,03851.5%
2025-08-0614,884037,58439.6%
2025-08-0529,234073,35439.9%
2025-08-0447,803084,02656.9%
2025-08-0148,8080197,61924.7%
2025-07-3110,392078,19813.3%
2025-07-308,891078,69611.3%
2025-07-2971,6500186,98738.3%
2025-07-2848,725153123,81939.4%
2025-07-2565,3830271,80924.1%
2025-07-2441,3340135,91830.4%
2025-07-2325,8281,072118,23321.8%
2025-07-2217,726063,36428.0%
2025-07-2151,0510180,94928.2%
2025-07-1823,315097,10224.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy